Showing results (1-10 of 402) with videos related to

Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2024
Endosomal escape: A bottleneck for LNP-mediated therapeuticsSushmita Chatterjee, Edo Kon, Preeti Sharma, et al.
Current Opinion in Biotechnology|October 29, 2021
Principles for designing an optimal mRNA lipid nanoparticle vaccineEdo Kon, Uri Elia, Dan Peer
Pharmaceutics|June 11, 2020
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell TransfectionEdo Kon, Inbal Hazan-Halevy, Daniel Rosenblum, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2019
Therapeutic mRNA delivery to leukocytesYasmin Granot-Matok, Edo Kon, Niels Dammes, et al.
Nature Reviews. Clinical Oncology|August 16, 2023
Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospectsEdo Kon, Nitay Ad-El, Inbal Hazan-Halevy, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 24, 2023
A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA DeliveryGonna Somu Naidu, Seok-Beom Yong, Srinivas Ramishetti, et al.
Science Advances|April 5, 2023
Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cellsSushmita Chatterjee, Gonna Somu Naidu, Inbal Hazan-Halevy, et al.
Advanced Drug Delivery Reviews|January 13, 2024
The immunostimulatory nature of mRNA lipid nanoparticlesPreeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Nature Nanotechnology|August 18, 2022
Nanotechnology-based strategies against SARS-CoV-2 variantsXiangang Huang, Edo Kon, Xuexiang Han, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 7, 2021
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian CancerManu Smriti Singh, Srinivas Ramishetti, Dalit Landesman-Milo, et al.
Pageof 41